Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR)

Experimental Eye Research

Volumn 120, Issue , 2014, Pages 55-60

  Scott, Andrew ^a   Powner, Michael B ^a   Fruttiger, Marcus ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Hypoxia; Mice; Oxygen induced retinopathy; Retinal vasculature; Tortuosity

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; MESSENGER RNA; PROTEIN P14; PROTEIN P17; THINNER; VASCULOTROPIN; PEPTIDES AND PROTEINS; RETINAL DEGENERATION 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; C3H/HE MOUSE; C57BL 6 MOUSE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE MUTATION; HUMAN; HYPEROXIA; HYPOXIA; MOUSE; MOUSE STRAIN; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN-INDUCED RETINOPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD VESSEL; RETINA DEGENERATION; RETINA NEOVASCULARIZATION; RETINAL THICKNESS; RETROLENTAL FIBROPLASIA; STRAIN DIFFERENCE; VASCULAR TORTUOSITY;

ANGIOGENESIS; HYPOXIA; MICE; OXYGEN-INDUCED RETINOPATHY; RETINAL VASCULATURE; TORTUOSITY;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; DISEASE MODELS, ANIMAL; HYPEROXIA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OXYGEN; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; RETINAL ARTERY; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893353624     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.12.020     Document Type: Article

References (52)

1. Agostini H., Boden K., Unsold A., Martin G., Hansen L., Fiedler U., Esser N., Marme D. Asingle local injection of recombinant VEGF receptor 2 but not of Tie2 inhibits retinal neovascularization in the mouse. Curr. Eye Res. 2005, 30:249-257.
2. Arden G.B. The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br. J. Ophthalmol. 2001, 85:366-370.
3. Barnett J.M., Yanni S.E., Penn J.S. The development of the rat model of retinopathy of prematurity. Doc. Ophthalmol. 2010, 120:3-12.
4. Chan C.K., Ip M.S., Vanveldhuisen P.C., Oden N.L., Scott I.U., Tolentino M.J., Blodi B.A. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion. Ophthalmology 2011, 118:1364-1372.
5. Chang B., Hawes N.L., Hurd R.E., Davisson M.T., Nusinowitz S., Heckenlively J.R. Retinal degeneration mutants in the mouse. Vis. Res. 2002, 42:517-525.
6. Checchin D., Sennlaub F., Levavasseur E., Leduc M., Chemtob S. Potential role of microglia in retinal blood vessel formation. Invest. Ophthalmol. Vis. Sci. 2006, 47:3595-3602.
7. Chen J., Connor K.M., Aderman C.M., Smith L.E. Erythropoietin deficiency decreases vascular stability in mice. J.Clin. Invest. 2008, 118:526-533.
8. Chiang M.F., Gelman R., Jiang L., Martinez-Perez M.E., Du Y.E., Flynn J.T. Plus disease in retinopathy of prematurity: an analysis of diagnostic performance. Trans. Am. Ophthalmol. Soc. 2007, 105:73-84.
9. Connor K.M., Krah N.M., Dennison R.J., Aderman C.M., Chen J., Guerin K.I., Sapieha P., Stahl A., Willett K.L., Smith L.E. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 2009, 4:1565-1573.
10. Dace D.S., Khan A.A., Kelly J., Apte R.S. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS.One 2008, 3:e3381.
11. Davitt B.V., Wallace D.K. Plus disease. Surv. Ophthalmol. 2009, 54:663-670.
12. Dorrell M.I., Aguilar E., Jacobson R., Trauger S.A., Friedlander J., Siuzdak G., Friedlander M. Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia 2010, 58:43-54.
13. Downie L.E., Pianta M.J., Vingrys A.J., Wilkinson-Berka J.L., Fletcher E.L. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy. Glia 2008, 56:1076-1090.
14. Fischer F., Martin G., Agostini H.T. Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy. J.Neuroinflam. 2011, 8:120.
15. Flynn J.T., O'Grady G.E., Herrera J., Kushner B.J., Cantolino S., Milam W. Retrolental fibroplasia: I. Clinical observations. Arch. Ophthalmol. 1977, 95:217-223.
16. Gelman R., Martinez-Perez M.E., Vanderveen D.K., Moskowitz A., Fulton A.B. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest. Ophthalmol. Vis. Sci. 2005, 46:4734-4738.
17. Grisan E., Foracchia M., Ruggeri A. Anovel method for the automatic grading of retinal vessel tortuosity. IEEE Trans. Med. Imaging 2008, 27:310-319.
18. Gu X., Samuel S., El Shabrawey M., Caldwell R.B., Bartoli M., Marcus D.M., Brooks S.E. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2002, 43:496-502.
19. Harder B.C., vonBaltz S., Jonas J.B., Schlichtenbrede F.C. Intravitreal bevacizumab for retinopathy of prematurity. J.Ocul. Pharmacol. Ther. 2011, 27:623-627.
20. Hartnett M.E., Martiniuk D., Byfield G., Geisen P., Zeng G., Bautch V.L. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest. Ophthalmol. Vis. Sci. 2008, 49:3107-3114.
21. Hartnett M.E., Penn J.S. Mechanisms and management of retinopathy of prematurity. N.Engl. J. Med. 2012, 367:2515-2526.
22. Hellstrom A., Perruzzi C., Ju M., Engstrom E., Hard A.L., Liu J.L., Albertsson-Wikland K., Carlsson B., Niklasson A., Sjodell L., LeRoith D., Senger D.R., Smith L.E. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5804-5808.
23. Higgins R.D., Yan Y., Geng Y., Zasloff M., Williams J.I. Regression of retinopathy by squalamine in a mouse model. Pediatr.Res. 2004, 56:144-149.
24. Higgins R.D., Yu K., Sanders R.J., Nandgaonkar B.N., Rotschild T., Rifkin D.B. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr. Eye Res. 1999, 18:20-27.
25. Holland D.R., Saunders R.A., Kagemann L.E., Bluestein E.C., Hutchinson A.K., Corson D.W., Harris A. Color doppler imaging of the central retinal artery in premature infants undergoing examination for retinopathy of prematurity. J.AAPOS 1999, 3:194-198.
26. Koch C.J. Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods Enzymol. 2002, 352:3-31.
27. Kondo T., Vicent D., Suzuma K., Yanagisawa M., King G.L., Holzenberger M., Kahn C.R. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J.Clin. Invest. 2003, 111:1835-1842.
28. Koreen S., Gelman R., Martinez-Perez M.E., Jiang L., Berrocal A.M., Hess D.J., Flynn J.T., Chiang M.F. Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology 2007, 114:e59-e67.
29. Kubota Y., Takubo K., Shimizu T., Ohno H., Kishi K., Shibuya M., Saya H., Suda T. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J.Exp. Med. 2009, 206:1089-1102.
30. Landers M.B., Stefansson E., Wolbarsht M.L. Panretinal photocoagulation and retinal oxygenation. Retina 1982, 2:167-175.
31. Lange C., Ehlken C., Stahl A., Martin G., Hansen L., Agostini H.T. Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model. Gr. Arch. Clin. Exp. Ophthalmol. 2009, 247:1205-1211.
32. Lucas R.J., Foster R.G. Neither functional rod photoreceptors nor rod or cone outer segments are required for the photic inhibition of pineal melatonin. Endocrinology 1999, 140:1520-1524.
33. Maier P., Unsoeld A.S., Junker B., Martin G., Drevs J., Hansen L.L., Agostini H.T. Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice. Gr. Arch. Clin. Exp. Ophthalmol. 2005, 243:593-600.
34. McVicar C.M., Colhoun L.M., Abrahams J.L., Kitson C.L., Hamilton R., Medina R.J., Durga D., Gardiner T.A., Rudd P.M., Stitt A.W. Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy. PLoS.One 2010, 5:e11870.
35. Neely D., Harris A., Hynes E., McNulty L., McCranor L., Siesky B., Plager D., Sprunger D., Roberts G. Longitudinal assessment of plus disease in retinopathy of prematurity using color Doppler imaging. J.AAPOS 2009, 13:509-511.
36. Ozaki H., Seo M.S., Ozaki K., Yamada H., Yamada E., Okamoto N., Hofmann F., Wood J.M., Campochiaro P.A. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathol. 2000, 156:697-707.
37. Peirson S.N., Butler J.N., Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 2003, 31:e73.
38. Penn J.S., Tolman B.L., Lowery L.A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest. Ophthalmol. Vis. Sci. 1993, 34:576-585.
39. Ritter M.R., Banin E., Moreno S.K., Aguilar E., Dorrell M.I., Friedlander M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J.Clin. Invest. 2006, 116:3266-3276.
40. Sato T., Kusaka S., Hashida N., Saishin Y., Fujikado T., Tano Y. Comprehensive gene-expression profile in murine oxygen-induced retinopathy. Br. J. Ophthalmol. 2009, 93:96-103.
41. Scott A., Fruttiger M. Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye (Lond.) 2010, 24:416-421.
42. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
43. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., D'Amore P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 1994, 35:101-111.
44. Sone H., Kawakami Y., Segawa T., Okuda Y., Sekine Y., Honmura S., Segawa T., Suzuki H., Yamashita K., Yamada N. Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. Life Sci. 1999, 65:2573-2580.
45. Unsoeld A.S., Junker B., Mazitschek R., Martin G., Hansen L.L., Giannis A., Agostini H.T. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice. Mol. Vis 2004, 10:468-475.
46. van Wijngaarden P., Brereton H.M., Coster D.J., Williams K.A. Genetic influences on susceptibility to oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2007, 48:1761-1766.
47. van Wijngaarden P., Brereton H.M., Coster D.J., Williams K.A. Hereditary influences in oxygen-induced retinopathy in the rat. Doc. Ophthalmol. 2009, 120:87-97.
48. West H., Richardson W.D., Fruttiger M. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development 2005, 132:1855-1862.
49. Wilson C.M., Cocker K.D., Moseley M.J., Paterson C., Clay S.T., Schulenburg W.E., Mills M.D., Ells A.L., Parker K.H., Quinn G.E., Fielder A.R., Ng J. Computerized analysis of retinal vessel width and tortuosity in premature infants. Invest. Ophthalmol. Vis. Sci. 2008, 49:3577-3585.
50. Wong C.G., Rich K.A., Liaw L.H., Hsu H.T., Berns M.W. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Curr. Eye Res. 2001, 22:140-147.
51. Zhang S.X., Ma J.X., Sima J., Chen Y., Hu M.S., Ottlecz A., Lambrou G.N. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am. J. Pathol. 2005, 166:313-321.
52. Zhang W., Yokota H., Xu Z., Narayanan S.P., Yancey L., Yoshida A., Marcus D.M., Caldwell R.W., Caldwell R.B., Brooks S.E. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model. Invest. Ophthalmol. Vis. Sci. 2011, 52:6384-6395.